Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Fungus

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   43881   clinical trials with a EudraCT protocol, of which   7295   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    85 result(s) found for: Fungus. Displaying page 1 of 5.
    1  2  3  4  5  Next»
    EudraCT Number: 2005-003717-33 Sponsor Protocol Number: P02095 Start Date*: 2005-09-13
    Sponsor Name:SCHERING-PLOUGH
    Full Title: Open-Label, limited access protocol of Posaconazole in invasive fungal infections.
    Medical condition: Profilaxys of invasive mycotic infections in high risk neutropenic patients.
    Disease: Version SOC Term Classification Code Term Level
    6.1 10017533 PT
    Population Age: Children, Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: View results
    EudraCT Number: 2008-007712-14 Sponsor Protocol Number: 1120081 Start Date*: 2009-01-17
    Sponsor Name:Erasme Hospital
    Full Title: Monitoring of serum concentrations of posaconazole given as prophylaxis or therapy.
    Medical condition: fungal infection
    Disease: Version SOC Term Classification Code Term Level
    9.1 10017533 Fungal infection LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: BE (Completed)
    Trial results: View results
    EudraCT Number: 2013-002848-93 Sponsor Protocol Number: UMCN-AKF13.02 Start Date*: 2014-01-23
    Sponsor Name:Radboud University Medical Centre
    Full Title: Pharmacokinetics of micafungin (Mycamin ®) as antifungal prophylaxis given twice weekly intravenously compared to micafungin given daily to patients at risk for developing an invasive fungal disease.
    Medical condition: prophylaxis for patients at high risk for invasive fungal diseases
    Disease: Version SOC Term Classification Code Term Level
    14.1 10021881 - Infections and infestations 10017533 Fungal infection PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Completed) BE (Completed)
    Trial results: View results
    EudraCT Number: 2016-001182-87 Sponsor Protocol Number: UMCN-AKF16.01 Start Date*: 2017-01-10
    Sponsor Name:Radboud University Medical Centre
    Full Title: Pharmacokinetics of posaconazole (Noxafil(R)) as prophylaxis for invasive fungal disease
    Medical condition: prophylaxis for patients at high risk for invasive fungal diseases
    Disease: Version SOC Term Classification Code Term Level
    19.0 10021881 - Infections and infestations 10017533 Fungal infection PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Completed) BE (Completed)
    Trial results: View results
    EudraCT Number: 2021-006868-24 Sponsor Protocol Number: UMCN-AKF-21.05 Start Date*: 2022-08-02
    Sponsor Name:Radboud university medical centre
    Full Title: Pharmacokinetics of fluconazole given orally or intravenously as prophylaxis or therapy to children and adolescents with invasive fungal infections (FOCUS)
    Medical condition: Invasive fungal disease
    Disease: Version SOC Term Classification Code Term Level
    20.0 10021881 - Infections and infestations 10017533 Fungal infection PT
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2017-000501-20 Sponsor Protocol Number: A1501082 Start Date*: 2017-03-09
    Sponsor Name:Pfizer, Inc.
    Full Title: Voriconazole In High-Risk Patients With Invasive Fungal Infections In Slovakia. An Open, Prospective, Non-comparative Study
    Medical condition: Invasive Fungal Infections
    Disease: Version SOC Term Classification Code Term Level
    19.1 10021881 - Infections and infestations 10017533 Fungal infection PT
    Population Age: In utero, Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: Outside EU/EEA
    Trial results: View results
    EudraCT Number: 2004-003745-40 Sponsor Protocol Number: GS-IT-131-0151 Start Date*: 2005-02-07
    Sponsor Name:GILEAD SCIENCES S.R.L.
    Full Title: Phase II pilot study on safety of administration of 3mg/kg/day three times a week until day 22 (21 days after transplantation day) and 7 mg/kg weekly from day 29 to the end of treatment ( day 50-8t...
    Medical condition: Fungal Infection High risk patients undergoing allogeneic stem-cell transplantation.
    Disease: Version SOC Term Classification Code Term Level
    14.1 10021881 - Infections and infestations 10017528 Fungal infectious disorders HLGT
    Population Age: Adults Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: View results
    EudraCT Number: 2008-008382-35 Sponsor Protocol Number: AIFA - FARM07YPBW Start Date*: 2010-04-08
    Sponsor Name:Azienda Ospedaliera di Perugia
    Full Title: Open , multicenter, randomized trial comparing two therapeutic approaches for the treatment of invasive fungal infections in neutropenic onco-hematologic patients.Empiric vs. ``presumptive`` (pree...
    Medical condition: opportunistic fungal infections in neutropenic onco-hematologic patients
    Disease: Version SOC Term Classification Code Term Level
    9.1 10017528 Fungal infectious disorders HLGT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2014-003306-33 Sponsor Protocol Number: UMCN-AKF-14.04 Start Date*: 2017-01-17
    Sponsor Name:Radboud university medical center
    Full Title: Liposomal amphotericin B (Ambisome) pharmacokinetics given as a single intravenous dose to obese patients (ASPEN).
    Medical condition: Prophylaxis for patients at risk for invasive fungal infection due to gastric bypass surgery.
    Disease: Version SOC Term Classification Code Term Level
    17.1 10021881 - Infections and infestations 10017533 Fungal infection PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Completed)
    Trial results: View results
    EudraCT Number: 2018-002613-35 Sponsor Protocol Number: UMCN-AKF-18.07 Start Date*: 2018-11-05
    Sponsor Name:Radboud university medical centre
    Full Title: Fluconazole pharmacokinetics, including bioavailability, in Obese subjects after an Intravenous and oral Administration (FOLIA).
    Medical condition: Pharmacokinetics of fluconazole in obese subjects.
    Disease: Version SOC Term Classification Code Term Level
    20.0 10021881 - Infections and infestations 10017533 Fungal infection PT
    Population Age: Adults Gender: Male, Female
    Trial protocol: NL (Completed)
    Trial results: View results
    EudraCT Number: 2010-019562-91 Sponsor Protocol Number: GS-EU-131-0247 Start Date*: 2010-12-13
    Sponsor Name:Gilead Sciences International Ltd
    Full Title: A Phase 3, Double-Blind, Multicenter, Randomized, Placebo Controlled Study to Assess the Efficacy, Safety and Tolerability of Prophylactic Liposomal Amphotericin B (AmBisome®) for the Prevention of...
    Medical condition: Invasive fungal infections (IFI) in subjects with Acute Lymphoblastic Leukemia (ALL) undergoing remission induction chemotherapy
    Disease: Version SOC Term Classification Code Term Level
    14.1 10021881 - Infections and infestations 10017533 Fungal infection PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: AT (Completed) PT (Completed) ES (Completed) DE (Completed) GR (Completed) BE (Completed) IT (Completed)
    Trial results: View results
    EudraCT Number: 2005-002800-40 Sponsor Protocol Number: A1501073 Start Date*: 2006-02-09
    Sponsor Name:Pfizer Ltd
    Full Title: Prospective, Open-label, Comparative, Multicenter Study of Voriconazole Compared to Itraconazole for the Primary Prophylaxis of Invasive Fungal Infections (IFI) in Subjects with Allogeneic Hematopo...
    Medical condition: Prophylaxis against invasive fungal infection following allogeneic hematopoietic stem cell transplantation.
    Disease: Version SOC Term Classification Code Term Level
    8 10017533
    Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed) CZ (Completed) ES (Completed) PT (Completed) GR (Completed)
    Trial results: View results
    EudraCT Number: 2018-001633-41 Sponsor Protocol Number: 18-01/Cic-C Start Date*: 2019-06-18
    Sponsor Name:Dermapharm AG
    Full Title: Double-blind, randomised clinical study comparing efficacy and safety of Ciclopirox Olamine Cream 10 mg/g (Test) vs. Batrafen® Cream (Reference) vs. Vehicle in patients with skin mycoses
    Medical condition: dermatomycoses
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004862 10012502 Dermatomycosis, unspecified LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2016-002271-97 Sponsor Protocol Number: F901318C21 Start Date*: 2017-04-07
    Sponsor Name:F2G Limited
    Full Title: An open label phase IIa clinical study to evaluate the safety and pharmacokinetics of oral F901318 (combined with fluconazole and posaconazole) for antifungal prophylaxis in patients undergoing che...
    Medical condition: Invasive fungal disease in patients with acute myeloid leukemia under chemotherapy
    Disease: Version SOC Term Classification Code Term Level
    19.1 10021881 - Infections and infestations 10017533 Fungal infection PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2016-000919-33 Sponsor Protocol Number: F901318C20 Start Date*: 2016-10-12
    Sponsor Name:F2G Limited
    Full Title: An open label phase IIa clinical study to evaluate the safety and pharmacokinetics of intravenous and oral F901318 (combined with caspofungin) for antifungal prophylaxis in patients undergoing chem...
    Medical condition: Infasive fungal disease in patients with acute myeloid leukemia under chemotherapy
    Disease: Version SOC Term Classification Code Term Level
    19.0 10021881 - Infections and infestations 10017533 Fungal infection PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2009-016936-11 Sponsor Protocol Number: FAR01-2009 Start Date*: 2011-05-12
    Sponsor Name:Servicio de Farmacia. Hospital Universitario de Bellvitge.
    Full Title: Estudio farmacocinético-farmacodinámico poblacional tras la administración oral o intravenosa de voriconazol en paciente crítico (fase IV)
    Medical condition: paciente crítico en tratamiento con voriconazol oral o endovenoso
    Disease: Version SOC Term Classification Code Term Level
    13.1 10038738 - Respiratory, thoracic and mediastinal disorders 10017537 Fungal lower respiratory tract infections HLT
    13.1 10042613 - Surgical and medical procedures 10066156 Empiric treatment LLT
    13.1 10021881 - Infections and infestations 10061354 Pneumonia fungal PT
    13.1 10022891 - Investigations 10053852 Fungus culture positive LLT
    13.1 10021881 - Infections and infestations 10017533 Fungal infection PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2021-000386-32 Sponsor Protocol Number: F901318/0041 Start Date*: 2022-01-21
    Sponsor Name:F2G Ltd.
    Full Title: A Phase III, adjudicator-blinded, randomised study to evaluate the efficacy and safety of treatment with olorofim versus treatment with AmBisome® followed by standard of care (SOC) in patients with...
    Medical condition: invasive fungal infections due to Aspergillus spp.
    Disease: Version SOC Term Classification Code Term Level
    20.0 10021881 - Infections and infestations 10017533 Fungal infection PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Ongoing) FR (Ongoing) BE (Ongoing) NL (Ongoing) IT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2010-018752-27 Sponsor Protocol Number: UMCN-AKF 10.01 Start Date*: 2010-11-19
    Sponsor Name:Radboud University Nijmegen Medical Centre
    Full Title: Pharmacokinetics of anidulafungin (Ecalta ®) given intravenously as antifungal prophylaxis to recipients of an allogeneic haematopoietic stem cell transplant following myeloablative chemotherapy or...
    Medical condition: Pharmacokinetics of anidulafungin (Ecalta ®) given intravenously as antifungal prophylaxis to recipients of an allogeneic haematopoietic stem cell transplant following myeloablative chemotherapy or...
    Disease: Version SOC Term Classification Code Term Level
    9.1 10017533 Fungal infection LLT
    12.1 10024324 Leukaemias HLGT
    Population Age: Adults Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2019-003842-34 Sponsor Protocol Number: MK-5592-127 Start Date*: Information not available in EudraCT
    Sponsor Name:Merck Sharp & Dohme LLC
    Full Title: A Phase 2, Open-Label, Single-Arm, Sequential-Panel Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Posaconazole (POS, MK-5592) Intravenous and Powder for Oral Suspension Formul...
    Medical condition: Invasive Fungal Infection
    Disease: Version SOC Term Classification Code Term Level
    20.0 10021881 - Infections and infestations 10017533 Fungal infection PT
    Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Under 18 Gender: Male, Female
    Trial protocol: PL (Trial now transitioned) Outside EU/EEA BE (Trial now transitioned) GR (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2007-004645-15 Sponsor Protocol Number: P03579 Start Date*: 2008-03-14
    Sponsor Name:Schering Plough Research Institute
    Full Title: Phase 1B Study of the Safety, Tolerance, and Pharmacokinetics of Oral Posaconazole in Immunocompromised Children With Neutropenia
    Medical condition: treatment and prophylaxis of invasive fungal infections; oropharyngeal candidiasis (OPC) and refractory OPC
    Disease: Version SOC Term Classification Code Term Level
    9.1 10050346 Oropharyngeal candidiasis LLT
    9.1 10017528 Fungal infectious disorders HLGT
    Population Age: Infants and toddlers, Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: IT (Prematurely Ended) DE (Prematurely Ended) NL (Prematurely Ended) GR (Prematurely Ended) Outside EU/EEA
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  4  5  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Mon May 20 03:19:41 CEST 2024 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA